Dimethylformamide → tert-butyl (2R)-2-[(2R)-4-(4-fluorophenyl)-3-oxomorpholin-2-yl]-2-hydroxyacetate
Reaktionsgleichung
Cl[CH2:2][CH2:3][N:4]([C:12](=[O:24])[C@H:13]([OH:23])[C@@H:14]([OH:22])[C:15]([O:17][C:18]([CH3:21])([CH3:20])[CH3:19])=[O:16])[C:5]1[CH:10]=[CH:9][C:8]([F:11])=[CH:7][CH:6]=1.CN(C=O)C>CC(O)(C)C.CS(C)=O>[F:11][C:8]1[CH:9]=[CH:10][C:5]([N:4]2[CH2:3][CH2:2][O:23][C@H:13]([C@@H:14]([OH:22])[C:15]([O:17][C:18]([CH3:21])([CH3:20])[CH3:19])=[O:16])[C:12]2=[O:24])=[CH:6][CH:7]=1Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
According to the Step 7-5 in synthetic method for EXAMPLE 7, compound 59-4 (1.62 g) and DMF were used instead of 7-4 and t-BuOH-DMSO to obtain compound 59-5 (400 mg) as a colorless amorphous solid.